iRhythm Technologies, Inc.

NasdaqGS:IRTC Stok Raporu

Piyasa değeri: US$2.0b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

iRhythm Technologies Yönetim

Yönetim kriter kontrolleri 2/4

iRhythm Technologies' CEO'su Quentin Blackford, Oct2021 tarihinde atandı, in görev süresi 2.75 yıldır. in toplam yıllık tazminatı $ 16.60M olup, şirket hissesi ve opsiyonları dahil olmak üzere 4.1% maaş ve 95.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.23% ine doğrudan sahiptir ve bu hisseler $ 5.37M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.5 yıl ve 7.3 yıldır.

Anahtar bilgiler

Quentin Blackford

İcra Kurulu Başkanı

US$16.6m

Toplam tazminat

CEO maaş yüzdesi4.1%
CEO görev süresi3yrs
CEO sahipliği0.2%
Yönetim ortalama görev süresi2.5yrs
Yönetim Kurulu ortalama görev süresi7.3yrs

Son yönetim güncellemeleri

Recent updates

Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Sep 19
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult

Jul 13
Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult

iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

May 13
iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

CEO Tazminat Analizi

Quentin Blackford'un ücretlendirmesi iRhythm Technologies'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$132m

Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

Tazminat ve Piyasa: Quentin 'nin toplam tazminatı ($USD 16.60M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 5.54M ).

Tazminat ve Kazançlar: Quentin şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Quentin Blackford (45 yo)

3yrs

Görev süresi

US$16,595,149

Tazminat

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Quentin Blackford
President3yrsUS$16.60m0.23%
$ 4.5m
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.5yrsUS$5.32m0.016%
$ 304.0k
Patrick Murphy
Chief Business & Legal Officer2.8yrsUS$5.33m0.031%
$ 599.0k
Chad Patterson
Chief Commercial Officer2.3yrsUS$5.77m0.025%
$ 493.0k
Mervin Smith
Executive Vice President of Business Operations1.3yrsVeri yok0.0023%
$ 45.8k
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officer1.2yrsVeri yok0.0029%
$ 57.0k
Daniel Wilson
Executive VP of Corporate Development & Investor Relations5.3yrsUS$3.54m0.098%
$ 1.9m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2.4yrsVeri yok0.075%
$ 1.5m
Stephanie Zhadkevich
Director of Investor Relationsno dataVeri yokVeri yok

2.5yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim: IRTC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Quentin Blackford
President2.8yrsUS$16.60m0.23%
$ 4.5m
Ralph Snyderman
Independent Director7.3yrsUS$233.12k0.032%
$ 632.7k
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno dataVeri yokVeri yok
Bruce Bodaken
Independent Director7.3yrsUS$240.25k0.030%
$ 592.0k
Abhijit Talwalkar
Independent Chairman8.4yrsUS$286.74k0.033%
$ 654.4k
R. Mead
Medical Director & Member of Scientific Advisory Boardno dataVeri yokVeri yok
James Quinn
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Cathleen Noel Merz
Independent Director6.5yrsUS$230.62k0.018%
$ 362.2k
Mark Rubash
Independent Director8.6yrsUS$248.12k0.034%
$ 664.0k
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno dataVeri yokVeri yok
Karen Ling
Independent Director2.9yrsUS$239.97k0.020%
$ 399.4k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno dataVeri yokVeri yok

7.3yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IRTC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.3 yıldır).